Kabra Drugs board to meet on May 29 to consider Q4 results

1 min read     Updated on 21 May 2026, 08:06 PM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Kabra Drugs Limited announced that its Board of Directors will meet on May 29, 2026, to consider and approve the unaudited financial results for the quarter ended March 31, 2026. The meeting is scheduled to take place at the company's Corporate Office in Chennai. Following regulatory protocols, the trading window for the company's shares has been closed for insiders and will reopen 48 hours after the results are declared.

powered bylight_fuzz_icon
40919778

*this image is generated using AI for illustrative purposes only.

Kabra Drugs Limited has scheduled a meeting of its Board of Directors for May 29, 2026. The meeting will be held at the company's Corporate Office in Chennai. The primary agenda for the gathering is to consider and approve the unaudited financial results for the quarter ended March 31, 2026.

The board will review the performance of the company for the fourth quarter of the fiscal year 2026. This approval is pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Additionally, the directors may discuss any other business with the permission of the chair.

In conjunction with the upcoming financial announcement, the company has closed the trading window for dealing in its shares. This restriction applies to all promoters, directors, designated employees, and concerned connected persons. The window will remain closed until 48 hours after the financial results are officially announced to the exchanges.

The intimation regarding the board meeting was submitted to BSE Limited on May 21, 2026. The company operates under the CIN L02423MP1989PLC005438 and is registered at its office in Indore, Madhya Pradesh.

Detail Information
Meeting Date May 29, 2026
Meeting Purpose To consider unaudited financial results for Q4FY26
Quarter Ended March 31, 2026
Trading Window Status Closed till 48 hours after result announcement

Historical Stock Returns for Kabra Drugs

1 Day5 Days1 Month6 Months1 Year5 Years
+4.87%+0.67%+1.44%-10.12%+118.40%+518.00%

How has Kabra Drugs Limited's revenue and profitability trended over the past four quarters, and what growth trajectory can investors expect for FY27?

Will the Q4FY26 results reveal any significant changes in Kabra Drugs' market share within the pharmaceutical distribution sector in India?

Are there any upcoming expansion plans, acquisitions, or new product launches that the board might announce alongside the Q4FY26 financial results?

Kabra Drugs Limited Issues Postal Ballot Notice for Name Change to Aanjaay Industries Limited and MOA Object Expansion

4 min read     Updated on 08 May 2026, 08:20 PM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Kabra Drugs Limited has issued a postal ballot notice dated May 8, 2026, seeking shareholder approval for two special resolutions: a name change to Aanjaay Industries Limited and an expansion of the Memorandum of Association's Main Objects Clause with twelve new sub-clauses spanning drones, defence, AI, electric vehicles, renewable energy, steel, healthcare, and agro industries. The Registrar of Companies has already approved the proposed new name. Remote e-voting is open from May 12, 2026, at 9:00 am IST to June 10, 2026, at 5:00 pm IST, with results to be declared on or before June 12, 2026.

powered bylight_fuzz_icon
39797418

*this image is generated using AI for illustrative purposes only.

Kabra Drugs Limited has issued a postal ballot notice dated May 8, 2026, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The notice, dispatched electronically to all shareholders whose e-mail addresses are registered as on the cut-off date of Friday, May 8, 2026, seeks member approval through remote e-voting for two special resolutions relating to a name change and an expansion of the company's business objects.

Proposed Name Change to Aanjaay Industries Limited

The Board of Directors, vide a board resolution dated January 1, 2026, approved a proposal to change the company's name from "Kabra Drugs Limited" to "Aanjaay Industries Limited" to reflect the company's new business directions and brand identity. The Registrar of Companies, Ministry of Corporate Affairs, has already granted approval for the proposed name "Aanjaay Industries Limited." The company has stated that the proposed name change would neither result in a change of objects, legal status, constitution, turnover, operations, or activities of the company, nor would it affect any rights or obligations of the company or its shareholders and other stakeholders.

A certificate from practicing Chartered Accountants M/s P P N And Company (Firm Registration Number: 013623S), Chennai, has been enclosed, certifying compliance with conditions prescribed under Sub-Regulation (1) of Regulation 45 of the SEBI Listing Regulations. The certificate confirms that the company has not changed its name since 1992, satisfying the requirement that at least one year must have elapsed since the last name change.

Expansion of Memorandum of Association Objects

The second special resolution proposes to insert twelve new sub-clauses (sub-clauses 4 to 15) after the existing sub-clause 3 in the Main Objects Clause III(A) of the Memorandum of Association. The Board of Directors approved this alteration at its meeting held on Tuesday, April 21, 2026. The company aims to diversify its business activities and capitalize on opportunities across multiple sectors. The proposed new business objects include:

  • Drones and defence: Manufacturing, fabricating, designing, and dealing in drone controllers, drones, drone cameras, and drone jammers; providing drone services for aerial topography, crop monitoring, surveillance, and disaster management; and manufacturing and maintaining equipment for assembly of fixed wing, rotary wing, land and naval platforms.
  • Electric vehicles: Designing, developing, and dealing in conventional or hydrogen internal combustion engines, battery electric drive systems, battery charging and swapping, fuel cell electric drive systems, and entire vehicles including public and individual transportation systems.
  • Renewable energy: Undertaking integrated renewable energy power projects including solar, wind, and other forms of renewable energy, energy storage including Battery Energy Storage Solutions (BESS), and providing Engineering, Procurement and Construction services.
  • Steel industry: Manufacturing, processing, importing, exporting, and dealing in all kinds of steel products including billets, rods, bars, sheets, coils, pipes, and alloys.
  • Healthcare and hospitals: Research and development in the healthcare sector; designing and operating hospitals, dispensaries, clinics, and laboratories; manufacturing and maintaining medical equipment; and establishing training institutions for medical and para-medical professionals.
  • Hospitality and accommodation: Providing and managing accommodation and hospitality services primarily for patients and their attendants, and operating theatres, health clubs, and recreational centers.
  • Dairy products: Manufacturing, processing, storing, and dealing in all types of dairy products including milk and allied products, and establishing and running dairy farms.
  • Agro industry: Establishing and running agro farms; cultivating and dealing in all kinds of agro products including food grains, seeds, trees, plants, fruits, and vegetables.
  • Artificial intelligence and technology: Research, design, development, manufacturing, and dealing in AI technologies, software solutions, and hardware products including machine learning, data analytics, cloud computing, cybersecurity, IoT equipment, and allied products.

E-Voting Schedule and Process Details

The remote e-voting process will be facilitated through CDSL. The key dates and details are as follows:

Parameter: Details
Cut-off Date for Eligibility: Friday, May 8, 2026
Commencement of Remote E-Voting: Tuesday, May 12, 2026, at 9:00 am (IST)
Conclusion of Remote E-Voting: Wednesday, June 10, 2026, at 5:00 pm (IST)
Result Declaration Deadline: On or before Friday, June 12, 2026
Scrutinizer: M/s. Jay Jain & Associates, Practicing Company Secretaries, Mumbai (Membership No. 55129, CP No. 23109)

M/s. Jay Jain & Associates, Practicing Company Secretaries, Mumbai, was appointed as the Scrutinizer at the Board meeting held on April 21, 2026, to conduct the postal ballot through the remote e-voting process in a fair and transparent manner. The result of the postal ballot shall be declared by the Chairman or any other duly authorized person of the Company on or before Friday, June 12, 2026, and will be communicated to the stock exchanges and uploaded on the company's website at www.kabradrugs.com . The last date of e-voting, i.e., Wednesday, June 10, 2026, shall be the date on which the resolutions would be deemed to have been passed, if approved by the requisite majority.

Historical Stock Returns for Kabra Drugs

1 Day5 Days1 Month6 Months1 Year5 Years
+4.87%+0.67%+1.44%-10.12%+118.40%+518.00%

How might Kabra Drugs' transition to Aanjaay Industries Limited impact investor sentiment, given the dramatic shift from pharmaceuticals to sectors like drones, defence, and electric vehicles?

Which of the nine proposed new business verticals is the company likely to prioritize first, and does it have the capital, management expertise, or partnerships in place to execute such a broad diversification strategy?

Could the simultaneous entry into highly regulated sectors such as defence drones, healthcare, and electric vehicles expose Aanjaay Industries to significant compliance and licensing risks that may delay revenue generation?

More News on Kabra Drugs

1 Year Returns:+118.40%